Therefore, IFITM2 is expected to be an effective target to improve the prognosis of CRC patients, and this study also provides some experimental basis for the targeted intervention of PI3K/AKT pathway-related molecules in the treatment of tumor metastasis. The gene discussed is AKT1; the disease is neoplasm.